22
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Artificial Intelligence in Gastroenterology

      Submit here before May 31, 2024

      About Digestion: 3.2 Impact Factor I 6.4 CiteScore I 0.914 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Accuracies of Endoscopic Diagnosis of Helicobacter pylori -Gastritis: Multicenter Prospective Study Using White Light Imaging and Linked Color Imaging

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction: The diagnosis of Helicobacter pylori infection status with white light imaging (WLI) is difficult. We evaluated the accuracies of using WLI and linked color imaging (LCI) for diagnosing H. pylori-active gastritis in a multicenter prospective study setting. Methods: Patients who underwent esophagogastroduodenoscopy were prospectively included. The image collection process was randomized and anonymous, and the image set included 4 images with WLI or 4 images with LCI in the corpus that 5 reviewers separately evaluated. Active gastritis was defined as positive when there was diffuse redness in WLI and crimson coloring in LCI. The H. pylori infection status was determined by the urea breath test and the serum antibody test. Cases in which both test results were negative but atrophy or intestinal metaplasia was histologically confirmed were defined as past infections. The primary endpoint was the diagnostic accuracies of WLI and LCI, and the secondary endpoint was inter-observer agreement. Results: Data for 127 patients were analyzed. The endoscopic diagnostic accuracy for active gastritis was 79.5 (sensitivity of 84.4 and specificity of 74.6) with WLI and 86.6 (sensitivity of 84.4 and specificity of 88.9) with LCI ( p = 0.029). LCI significantly improved the accuracy in patients with past infections over WLI (36.8 in WLI and 78.9 in LCI, p < 0.01). The κ values were 0.59 in WLI and 0.70 in LCI. Conclusions: LCI is useful for endoscopic diagnosis of H. pylori-active or inactive gastritis, and it is advantageous for patients with past infections of inactive gastritis.

          Related collections

          Author and article information

          Journal
          DIG
          Digestion
          10.1159/issn.0012-2823
          Digestion
          S. Karger AG
          0012-2823
          1421-9867
          2020
          September 2020
          23 July 2019
          : 101
          : 5
          : 624-630
          Affiliations
          [_a] aDepartment of Gastroenterology, Hokkaido University Hospital, Sapporo, Japan
          [_b] bDepartment of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan
          [_c] cDepartment of Gastroenterology, Asahi University Hospital, Gifu, Japan
          [_d] dDepartment of Endoscopy, Hiroshima Prefectural Hospital, Hiroshima, Japan
          [_e] eDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan
          [_f] fDepartment of Gastroenterology and Hepatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
          [_g] gDepartment of Gastroenterology, National Hospital Organization Hakodate Hospital, Hakodate, Japan
          Author notes
          *Shoko Ono, Department of Gastroenterology, Hokkaido University Hospital, West 5, North 14, Kita-ku, Sapporo 060-8648 (Japan), E-Mail onosho@med.hokudai.ac.jp
          Author information
          https://orcid.org/0000-0002-0498-0144
          https://orcid.org/0000-0001-5443-788X
          Article
          501634 Digestion 2020;101:624–630
          10.1159/000501634
          31336366
          f9d68e58-b88a-4c6f-b8c5-9c061f8d509f
          © 2019 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 01 April 2019
          : 21 June 2019
          Page count
          Figures: 3, Tables: 3, Pages: 7
          Categories
          Research Article

          Oncology & Radiotherapy,Gastroenterology & Hepatology,Surgery,Nutrition & Dietetics,Internal medicine
          13c urea breath test, Helicobacter pylori ,Endoscopy,Gastritis

          Comments

          Comment on this article